Error: Could not add to watchlist. X

Credit Suisse Lux Biotechnology Equity Fund

+ Watchlist
CR4A:GR
Berlin
449.00
EUR
11.30
2.58%
As of 14:45:07 ET on 07/01/2015.
Open
435.41
Day Range
435.41 - 452.34
Volume
23
Previous Close
437.70
52Wk Range
237.62 - 472.32
1 Yr Return
78.91%
NAV (on -)
118.25
Total Assets (m EUR) (on 06/30/2015)
262.149
Inception Date
11/06/2001
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
IRENE BEATRICE PUETTNER
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
-
3 Mo Return
-3.10%
3 Yr Return
43.57%
5 Yr Return
35.63%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 47.00 k 17.57 m 7.26
Gilead Sciences Inc 167.48 k 16.83 m 6.95
Amgen Inc 105.97 k 16.73 m 6.91
Celgene Corp 140.28 k 15.16 m 6.26
Incyte Corp 130.00 k 12.63 m 5.22
BioMarin Pharmaceutical Inc 109.44 k 12.26 m 5.07
Regeneron Pharmaceuticals Inc 25.00 k 11.44 m 4.72
Vertex Pharmaceuticals Inc 85.00 k 10.48 m 4.33
Medivation Inc 80.00 k 9.66 m 3.99
Alexion Pharmaceuticals Inc 52.75 k 8.93 m 3.69
Profile
Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
ADDRESS
Credit Suisse AG
PHONE
-